In the BioHarmony Drug Report Database

"Preview" Icon

Azilsartan medoxomil

Edarbi (azilsartan medoxomil) is a small molecule pharmaceutical. Azilsartan medoxomil was first approved as Edarbi on 2011-02-25. It is used to treat hypertension in the USA. It has been approved in Europe to treat hypertension. Edarbi’s patents are valid until 2028-03-26 (FDA).

 

Trade Name

 

Edarbi
 

Common Name

 

azilsartan medoxomil
 

ChEMBL ID

 

CHEMBL2028661
 

Indication

 

hypertension
 

Drug Class

 

Angiotensin II receptor antagonists

Image (chem structure or protein)

Azilsartan medoxomil structure rendering